Clinical Trial Update: CVT-SFA First in Human Trial for Treatment of Superficial Femoral Artery or Proximal Popliteal Artery [NA]

View source ↗

Summary

Abbott Medical Devices reports completion of a first-in-human trial of the CVT-SFA device for treatment of disease in the superficial femoral and proximal popli…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Femoral Artery Occlusion
• Femoral Artery Stenosis
• Peripheral Artery Disease
• Popliteal Artery Occlusion
• Popliteal Artery Stenosis

Drugs mentioned

• CVT-SFA

Snippet

Sponsor: Abbott Medical Devices | Conditions: Femoral Artery Stenosis, Popliteal Artery Stenosis | NA | Status: COMPLETED | Results posted: 2025-08-07